Amplify serialization to build trust
Our Carly Guenther explains how manufacturers can build patient trust and ensure counterfeit COVID-19 related treatments.
Harnessing the power of networks via the INTIENT platform
Accenture’s INTIENT platform enables innovation by connecting an ecosystem of partners.
Is COVID-19 changing our value proposition to HCPs?
As the pandemic stretches on, pharma companies have realized they need to do more than just communicate product information in order to be relevant.